Solid Biosciences (SLDB) Net Equity Issued and Repurchased (2017)
Solid Biosciences' (SLDB) quarterly Net Equity Issued and Repurchased came in at -$500000.0 in Q2 2017, down 102.0% quarter-over-quarter from $25.0 million in Q1 2017.
Solid Biosciences (SLDB) Net Equity Issued and Repurchased (2017) Analysis & Trends
Solid Biosciences has disclosed Net Equity Issued and Repurchased across 1 years of filings, most recently posting -$500000.0 for Q2 2017.
- Net Equity Issued and Repurchased for Q2 2017 came in at -$500000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $24.5 million (changed N/A YoY), and the FY2017 annual result was $24.5 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased came in at -$500000.0 for Q2 2017 at Solid Biosciences, down from $25.0 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $25.0 million in Q1 2017 to a low of -$500000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Solid Biosciences | 789.54 Mn | 408.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -500,000.00 |
| Mar 31, 2017 | 25.00 Mn |